CUSIP: 14888D109
Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,321,846
-
Share change
-
-80,097
-
Total reported value
-
$7,295,000
-
Price per share
-
$1.68
-
Number of holders
-
26
-
Value change
-
-$156,112
-
Number of buys
-
3
-
Number of sells
-
13
Quarterly Holders Quick Answers
What is CUSIP 14888D109?
CUSIP 14888D109 identifies CBIO - CATALYST BIOSCIENCES INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2016
-
Previous quarter:
Q4 2015
Recent filing periods for CUSIP 14888D109:
Institutional Holders of CATALYST BIOSCIENCES INC - COM (CBIO) as of Q1 2016
As of 31 Mar 2016,
CATALYST BIOSCIENCES INC - COM (CBIO) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,321,846 shares.
The largest 10 holders included
Essex Woodlands Health Ventures, Inc., BVF INC/IL, NEA Management Company, LLC, UBS Group AG, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., DG Capital Management, LLC, Colorado Capital Management, Inc., venBio Select Advisor LLC, and DAFNA Capital Management LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.